Cancer incidence in Khyber Pakhtunkhwa, Pakistan, 2020.
Cancer incidence
Khyber Pakhtunkhwa
Malignancies
Pakistan
Population-based
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
14 09 2023
14 09 2023
Historique:
received:
13
04
2023
accepted:
04
09
2023
medline:
18
9
2023
pubmed:
15
9
2023
entrez:
14
9
2023
Statut:
epublish
Résumé
To present the population-based cancer statistics for Khyber Pakhtunkhwa (KP), Pakistan, an incidence study was conducted at the Shaukat Khanum Memorial Cancer Hospital and Research Centre (SKMCH&RC) in Lahore, Pakistan, in 2023. Records from various centres on new cancers diagnosed among residents of KP between January and December 2020 were gathered. Both active and passive methods of data collection were applied, and the information was saved in a central repository at SKMCH&RC. The incidence rates were computed by age group and sex and presented per 100,000 population. Among children (0-14 years), the Age-Standardised Incidence Rate (ASIR) was 4.0 in girls and 6.1 in boys, and haematologic malignancies were more prevalent; in adolescents (15-19 years), the ASIR was 7.7 in females, 9.4 in males, and bone tumours, haematologic malignancies, and neurological cancers were prominent; in adult females (> / = 20 years), the ASIR was 84.9, and cancers of the breast, digestive system, and reproductive organs were predominant; and adult males, the ASIR was 73.0, and cancers of the gastrointestinal tract, lip/oral cavity/pharynx, prostate, and Non-Hodgkin Lymphoma (NHL) were common. It is crucial to investigate the aetiology of these diseases at the community level because dietary elements, infectious diseases, and tobacco use all appear to be significant contributors. Prospective studies could play a key role in highlighting the factors linked to these diseases. Therefore, cancer registration must continue in conjunction with the exploration of risk factors.
Sections du résumé
BACKGROUND
To present the population-based cancer statistics for Khyber Pakhtunkhwa (KP), Pakistan, an incidence study was conducted at the Shaukat Khanum Memorial Cancer Hospital and Research Centre (SKMCH&RC) in Lahore, Pakistan, in 2023.
METHODS
Records from various centres on new cancers diagnosed among residents of KP between January and December 2020 were gathered. Both active and passive methods of data collection were applied, and the information was saved in a central repository at SKMCH&RC. The incidence rates were computed by age group and sex and presented per 100,000 population.
RESULTS
Among children (0-14 years), the Age-Standardised Incidence Rate (ASIR) was 4.0 in girls and 6.1 in boys, and haematologic malignancies were more prevalent; in adolescents (15-19 years), the ASIR was 7.7 in females, 9.4 in males, and bone tumours, haematologic malignancies, and neurological cancers were prominent; in adult females (> / = 20 years), the ASIR was 84.9, and cancers of the breast, digestive system, and reproductive organs were predominant; and adult males, the ASIR was 73.0, and cancers of the gastrointestinal tract, lip/oral cavity/pharynx, prostate, and Non-Hodgkin Lymphoma (NHL) were common.
CONCLUSIONS
It is crucial to investigate the aetiology of these diseases at the community level because dietary elements, infectious diseases, and tobacco use all appear to be significant contributors. Prospective studies could play a key role in highlighting the factors linked to these diseases. Therefore, cancer registration must continue in conjunction with the exploration of risk factors.
Identifiants
pubmed: 37710250
doi: 10.1186/s12889-023-16686-5
pii: 10.1186/s12889-023-16686-5
pmc: PMC10500738
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1785Commentaires et corrections
Type : ErratumIn
Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
BMJ Open. 2021 Aug 19;11(8):e047049
pubmed: 34413099
Asian Pac J Cancer Prev. 2014;15(16):6715-20
pubmed: 25169514
Syst Rev. 2016 Aug 24;5(1):142
pubmed: 27558171
Asian Pac J Cancer Prev. 2015;16(3):1145-50
pubmed: 25735346
J Pak Med Assoc. 2022 Apr;72(4):685-690
pubmed: 35614602
J Coll Physicians Surg Pak. 2023 Jun;33(6):625-632
pubmed: 37300256
PLoS One. 2017 Jul 10;12(7):e0180445
pubmed: 28692704
BMC Genomics. 2015 Mar 12;16:172
pubmed: 25887915
Urol Oncol. 2013 Nov;31(8):1419-29
pubmed: 23141781
Viral Immunol. 2020 Jun;33(5):396-403
pubmed: 32109202
Tob Control. 2021 Sep;30(5):548-552
pubmed: 32817262
Nicotine Tob Res. 2019 Jan 1;21(1):32-40
pubmed: 29294113
J Pak Med Assoc. 2019 May;69(5):738-740
pubmed: 31105301
Asian Pac J Cancer Prev. 2020 Nov 01;21(11):3251-3258
pubmed: 33247682
Mol Biol Rep. 2023 Jul;50(7):6087-6096
pubmed: 37300745
J Pak Med Assoc. 2013 Jan;63(1):25-7
pubmed: 23865127